High Court Seems Unconvinced by Merck in Vioxx Arguments
U.S. Supreme Court justices seemed reluctant Monday to give the pharmaceutical company Merck & Co. a “statute of limitations” way out of defending against a securities fraud class action involving Vioxx. The Court heard arguments in the latest round in a continuing battle over how easy or hard it should be to file class actions. Companies want speed, while shareholder and consumer groups insist
Read more here
Statistics Expert Testifies in Vioxx Case
Jurors on a product liability case over the painkiller Vioxx heard Thursday from a medical statistics expert, a day after an executive for manufacturer Merck & Co. said the company tried to speed development of the drug.
More...
Vioxx jury completes first day of deliberations
ANGLETON, Texas Jurors in the nation's first Vioxx-related civil trial ended their first day of deliberation after seven hours Thursday. They were to resume early today.
Read more here
Jury gets case of Alabama man blaming Vioxx for heart attack
BIRMINGHAM, Ala. (AP) — A state court jury began deliberating Friday in the case of an Alabama man who is seeking millions on his claim that the painkiller Vioxx was to blame for a heart attack he suffered nearly five years ago.
More...